Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
1% to $0.55 per share. Analysts remain wary of investing in Abbott, due to widespread uncertainty about the direction of U.S. health reform and generic competition. Its most successful drug at present is Humira, an anti-tumor necrosis factor (TNF) drug (Abbot Laboratories, 2011, Zacks Equity Research). However, exclusive dependence on a single drug does not bode well for the company's future. The eternal problem for profitability with drug companies is that all new drugs patents expire after a certain period, and are allowed to be produced more cheaply in generic form. A pharmaceutical company needs to show consistent innovation to stay afloat. Combined with the difficulties in curtailing overhead costs, Abbott should reconsider its approach to spending, trimming administrative costs and emphasizing R&D.
Abbott needs to show sustained innovation in its R&D sector, specifically in drugs that are likely to yield a high profit. It must also promote more aggressively its personal care products, such as Ensure (a nutritional supplement), Pedialyte (an electrolyte drink for toddlers), and antacids. Abbott has shown substantial innovation in its drugs designed to treat AIDS and other autoimmune disorders, and it must continue to distinguish itself as...
However, to ensure a steady stream of revenue, it must also 'shore up' its non-drug related product lines and its medical equipment (such as its stents). Abbott must demonstrate that its products are worth the price consumers pay and emphasize their superiority of effectiveness and functioning, versus cheaper generic or low-cost brands.
References
Abbot Laboratories. (2011). Businessweek. Retrieved July 16, 2011 at http://investing.businessweek.com/research/stocks/financials/financials.asp?ticker=ABT:U.S.
Abbott Laboratories: Assets. (2011). Stock Analysis. Retrieved July 16, 2011 at http://www.stock-analysis-on.net/NYSE/Company/Abbott-Laboratories/Financial-Statement/Assets
Abbot Laboratories. (2011). Zacks Equity Research. Retrieved July 16, 2011 at http://www.zacks.com/pr/57043/The+Zacks+Analyst+Blog+Highlights%3A+Google%2C+Abbott+Laboratories%2C+Amgen%2C+Pfizer+and+Johnson+%26amp%3B+Johnson
Abbott Laboratories: Long-term debt and solvency analysis. (2011). Stock Analysis. Retrieved July 16, 2011 at http://www.stock-analysis-on.net/NYSE/Company/Abbott-Laboratories/Ratios/Long-term-Debt-and-Solvency
Their sole purpose is conducting medical and science research. These include providing funding as well as facilities to: individual scientists, universities and in some cases private corporations. If Abbott Labs can form some kind of partnership with them, this could help to address the issues that they are facing as far as the reduction in funding that they are receiving from their projects. ("Howard Hughes Medical Institute," 2011) (Drefius,
Abbott must expand its pharmaceutical research endeavors to ensure that it is consistently generating new drugs that are superior in quality to its competitors. Good research requires constant infusions of new talent and knowledge into the company. Problem 3: Too much emphasis on high-cost product lines Some of Abbott's product lines target a higher-end clientele, such as its animal wellness and vision care products, for which there may not be sufficient demand
Pag). Some business will continue as usual, of course: Abbott's nutrition division, based in Columbus, Ohio and employing approximately 2,000 people, announced that the nutrition unit will "fall under the umbrella of a new medical products company that will retain the Abbott name in a split announced Wednesday" (Rouan n.pag). In addition, the announcement has apparently met with international investor approval: "At the news, Abbott's shares went up 7.3% in
It must also begin to develop a test population of genetically suitable subjects. However, Abbott also faces a potential weakness within the organization in terms of its distribution of medications. Through exclusive sourcing agreements Abbott has attempted to control the introduction of unsafe product in the U.S. But Abbott's lack of control of overseas manufacturing facilities production has allowed far too many opportunities for illegal distribution, causing the brand to
A favorite target for conspiracists today as well as in the past, a group of European intellectuals created the Order of the Illuminati in May 1776, in Bavaria, Germany, under the leadership of Adam Weishaupt (Atkins, 2002). In this regard, Stewart (2002) reports that, "The 'great' conspiracy organized in the last half of the eighteenth century through the efforts of a number of secret societies that were striving for
Jesus' Teachings, Prayer, & Christian Life "He (Jesus) Took the Bread. Giving Thanks Broke it. And gave it to his Disciples, saying, 'This is my Body, which is given to you.'" At Elevation time, during Catholic Mass, the priest establishes a mandate for Christian Living. Historically, at the Last Supper, Christ used bread and wine as a supreme metaphor for the rest of our lives. Jesus was in turmoil. He was